Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial - The Lancet

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial  The Lancet

Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы

Inside Ontario’s ‘scary’ child-welfare system where kids are ‘commodities’ - Global News